|
44
|
129
|
7ze6A |
Brd4 in complex with fraglite10 |
|
44
|
129
|
7zfnAAA |
Brd4 in complex with fraglite24 |
|
42
|
129
|
7zfyAAA |
Brd4 in complex with peplite-gly |
|
43
|
129
|
7zg2AAA |
Brd4 in complex with acetyl-lys |
|
44
|
129
|
7zfuAAA |
Brd4 in complex with peplite-pro |
|
42
|
129
|
7zfzAAA |
Brd4 in complex with peplite-val |
|
45
|
129
|
7zg1AAA |
Brd4 in complex with peplite-tyr |
|
43
|
129
|
7zfsAAA |
Brd4 in complex with fraglite32 |
|
43
|
129
|
7zefA |
Brd4 in complex with fraglite22 |
|
43
|
129
|
7zftAAA |
Brd4 in complex with fraglite33 |
|
42
|
129
|
7zfvA |
Brd4 in complex with peplite-ala |
|
45
|
127
|
8eadA |
Crystal structure of the first bromodomain (bd1) of human brd4 in complex with dual brd4-jak2 inhibitor ma9-177 |
|
34
|
116
|
7w3dA |
Crystal structure of brd4 bromodomain 1 (bd1) in complex with n2-(1,2,3-benzotriazol-5-yl)-n3-(dimethylsulfamoyl)-n6-[(2s)-1-methoxypropan-2-yl]pyridine-2,3,6-triamine |
|
44
|
127
|
7t3fA |
Development of brd4 inhibitors as arsenicals antidotes |
|
41
|
127
|
7ruiA |
Bromodomain-containing protein 4 (brd4) bromodomain 1 (bd1) complexed with xr844 |
|
40
|
113
|
7ruhA |
Bromodomain-containing protein 4 (brd4) bromodomain 2 (bd2) complexed with xr844 |
|
42
|
125
|
7utyA |
First bromodomain of brd4 liganded with compound 2c |
|
42
|
125
|
7uznA |
Crystal structure of the first bromodomain of human brd4 in complex with bmt-206059 aka 2-{(3m)-3-(1,4-dimethyl-1h-1,2,3-triazol-5-yl)-8-fluoro-5-[(s)-(oxan-4-yl)(phenyl)methyl]-5h-pyrido[3,2-b]indol-7-yl}propan-2-ol, triply deuterated on the 4-methyl group |
|
42
|
131
|
7v2jA |
Crystal structure of the first bromodomain of human brd4 in complex with the inhibitor 33 |
|
44
|
131
|
7v1uA |
Crystal structure of the first bromodomain of human brd4 in complex with the inhibitor zj12 |
|
41
|
128
|
7wl4A |
Crystal structure of the first bromodomain of human brd4 in complex with the inhibitor slp-50 |
|
34
|
109
|
7wkyA |
Crystal structure of the first bromodomain of human brd4 in complex with the inhibitor y13153 |
|
33
|
108
|
7wjsA |
Crystal structure of the first bromodomain of human brd4 in complex with the inhibitor y13157 |
|
44
|
126
|
7rjrA |
Crystal structure of human bromodomain containing protein 4 (brd4) in complex with bcltf1 |
|
44
|
127
|
7rmdA |
Crystal structure of the first bromodomain of human brd4 in complex with sj001011461-1 |
|
41
|
125
|
7rjoA |
Crystal structure of human bromodomain containing protein 4 (brd4) in complex with hnrnpk |
|
45
|
127
|
7b1tA |
Crystal structure of brd4(1) in complex with the inhibitor mpm6 |
|
0
|
8
|
7rjqB |
Crystal structure of human bromodomain containing protein 4 (brd4) in complex with ilf3 |
|
44
|
127
|
7rjpA |
Crystal structure of human bromodomain containing protein 4 (brd4) in complex with shmt |
|
42
|
125
|
7rjqA |
Crystal structure of human bromodomain containing protein 4 (brd4) in complex with ilf3 |
|
43
|
127
|
7rn2A |
Crystal structure of the first bromodomain of human brd4 in complex with sj001010551-2 |
|
0
|
5
|
7rjrB |
Crystal structure of human bromodomain containing protein 4 (brd4) in complex with bcltf1 |
|
44
|
127
|
7mr9A |
Crystal structure of the first bromodomain (bd1) of human brd4 bound to nc-ii-153 |
|
44
|
127
|
7mrbA |
Crystal structure of the first bromodomain (bd1) of human brd4 bound to nc-iii-53 |
|
42
|
126
|
7mraA |
Crystal structure of the first bromodomain (bd1) of human brd4 bound to nc-ii-259 |
|
35
|
123
|
7fh2A |
Crystal structure of the first bromodomain of brd4 in complex with 16d10 |
|
42
|
111
|
7ko0A |
Crystal structure of the second bromodomain (bd2) of human brd4 bound to sg3-179 |
|
42
|
125
|
7p6vAAA |
N-terminal bromodomain of human brd4 with compound 3ag |
|
40
|
126
|
7p6yAAA |
N-terminal bromodomain of human brd4 with compound 5ef |
|
40
|
127
|
7p6wAAA |
N-terminal bromodomain of human brd4 with compound 3bg |
|
42
|
124
|
7o18AAA |
N-terminal bromodomain of human brd4 with i-bet282 |
|
40
|
126
|
7mceA |
Crystal structure of the first bromodomain of human brd4 in complex with 2-{(7p)-7-(1,4-dimethyl-1h-1,2,3-triazol-5-yl)-8-fluoro-5-[(s)-(oxan-4-yl)(phenyl)methyl]-5h-pyrido[3,2-b]indol-3-yl}propan-2-ol |
|
44
|
123
|
7m16A |
Triazole-based bet family bromodomain inhibitor bound to brd4(d1) |
|
41
|
127
|
7k6hA |
Crystal structure of the first bromodomain (bd1) of human brd4 bound to xmd8-92 |
|
41
|
127
|
7k6gA |
Crystal structure of the first bromodomain (bd1) of human brd4 bound to erk5-in-1 |
|
41
|
127
|
7jkyA |
Bromodomain-containing protein 4 (brd4) bromodomain 1 (bd1) complexed with yf3-126 |
|
40
|
111
|
7jkzA |
Bromodomain-containing protein 4 (brd4) bromodomain 2 (bd2) complexed with yf3-126 |
|
42
|
127
|
7jkwA |
Bromodomain-containing protein 4 (brd4) bromodomain 1 (bd1) complexed with zn1-99 |
|
47
|
129
|
7dhsA |
Crystal structure analysis of the brd4 |
|
42
|
127
|
7axrA |
Crystal structure of brd4(1) bound to the dual bet-hdac inhibitor lsh24 |
